Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emma Blamont
Institution:
Scleroderma and Raynaud's UK
Observed institution:
Scleroderma and Raynaud's UK
ORCID:
0000-0002-5483-2772
Observed ORCID:
0000-0002-5483-2772
OpenAlex ID:
A5101483211
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis
2024
·
Christopher P Denton
, Enrico De Lorenzis
, et al.
·
Rheumatology
·
115
PDF
Management of systemic sclerosis: British Society for Rheumatology guideline scope
2022
·
Christopher P Denton
, Enrico De Lorenzis
, et al.
·
Rheumatology Advances in Practice
·
17
PDF
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis—executive summary
2024
·
Christopher P Denton
, Enrico De Lorenzis
, et al.
·
Rheumatology
·
13
A Scleroderma and Raynaud’s UK (SRUK) national survey to explore rheumatologists’ awareness, approaches to diagnosis and management and training needs within systemic sclerosis
2024
·
Emma Blamont
, Sue Farrington
, et al.
·
Rheumatology Advances in Practice
·
3
PDF
The clinical impact of systemic sclerosis-related calcinosis—results of a patient survey
2022
·
Emma Pearson
, Emma Blamont
, et al.
·
Rheumatology
·
3
Comment on: The 2024 British Society for Rheumatology guideline for management of systemic sclerosis. Reply
2024
·
Christopher P Denton
, for the Systemic Sclerosis BSR Guideline Working Group
, et al.
·
Rheumatology
·
2
PDF
Show more works
View as search
Works count:
6
Citation count:
153
H-index:
3
I10-index:
3
Year
Topic
Type
